Monograph Details
|
|
Eye Disorders
> Ocular allergy/inflammation
|
|
VASOCON-A |
| Manufacturer |
|
Novartis Ophthalmics |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Vasoconstrictor. |
| Generic Name |
|
Antazoline phosphate 0.5%, naphazoline HCl 0.05%; oph. soln; contains benzalkonium chloride. |
| Indications |
|
Temporary relief of ocular redness and itching. |
| Adults and Children |
|
<6yrs: not recommended. ≥6yrs: 1–2 drops up to 4 times daily. |
| Contraindications |
|
Narrow-angle glaucoma. Concurrent MAOIs. Contact lens wear. |
| Precautions |
|
Avoid prolonged use. Hypertension. Cardiovascular disease. Urinary hesitancy. Diabetes. Pregnancy. Nursing mothers. |
| Interactions |
|
Hypertensive crisis with MAOIs. |
| Adverse Reactions |
|
Mydriasis, increased IOP, local irritation, allergic dermatitis, sensitization, systemic effects if absorbed, may precipitate narrow-angle glaucoma. |
| How Supplied |
|
Soln—15mL |
|
|
|
|
